Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome

.

Source: Expert Opinion on Biological Therapy - June 27, 2022 Category: Drugs & Pharmacology Authors: Emanuele Trovato Pietro Rubegni Francesca Prignano Source Type: research